title: Reflecting on a decade of metabolite screening and monitoring.
abstract: The last 10 years have witnessed robust debate within the bioanalytical community and regulatory authorities on the topic of metabolite monitoring and safety assessment. Of particular interest to regulated bioanalytical laboratories was the acceptance by the US FDA and other major regulatory bodies of a tiered approach to bioanalytical assay validation. The tiered approach defines a sliding scale of regulatory rigor for the evaluation of significant human metabolites that encompasses a range of assessments from semi-quantitative assays to fully validated assays, all of which can be used in support of regulatory submissions. This article describes the utilization of a tiered approach at Bristol-Myers Squibb and the decision trees guiding the selection of the appropriate level of assay qualification. Case studies illustrate how decisions are made, how different scientific situations influence the assay choice, and what criteria may be set to continue or discontinue metabolite monitoring in later drug development.
authors.affiliation: Analytical & Bioanalytical Development, Bristol-Myers Squibb, Princeton, NJ 08540, USA.
authors.forename: Anne-Françoise
authors.initials: AF
authors.lastname: Aubry
authors.forename: Lisa J
authors.initials: LJ
authors.lastname: Christopher
authors.forename: Jian
authors.initials: J
authors.lastname: Wang
authors.forename: Mingshe
authors.initials: M
authors.lastname: Zhu
authors.forename: Giridhar
authors.initials: G
authors.lastname: Tirucherai
authors.forename: Mark E
authors.initials: ME
authors.lastname: Arnold
mesh_terms: D054316:Biomarkers, Pharmacological / Q000032:analysis* / Q000737:chemistry; D004353:Drug Evaluation, Preclinical / Q000379:methods* / Q000639:trends*; D016903:Drug Monitoring / Q000379:methods* / Q000639:trends*; D006801:Humans; D004364:Pharmaceutical Preparations / Q000032:analysis / Q000737:chemistry* / Q000378:metabolism
chemical_list: D054316:Biomarkers, Pharmacological; D004364:Pharmaceutical Preparations